Literature DB >> 21665887

The EMT regulator slug and lung carcinogenesis.

Jin-Yuan Shih1, Pan-Chyr Yang.   

Abstract

Lung cancer is the leading cause of cancer death worldwide. Cancer metastasis and resistance to treatment (including radiotherapy, chemotherapy and targeted therapy) are two major causes for the poor survival of lung cancer patients. Epithelial-mesenchymal transition (EMT) is involved in cancer cell invasion, resistance to apoptosis and stem cell features. The process of EMT is controlled by a group of transcriptional factors, zinc finger proteins and basic helix-loop-helix factors. Signaling pathways activated by intrinsic or extrinsic stimuli converge on these transcriptional factors and regulated the phenotypic changes of cancer cells. These EMT regulators may play an important role in cancer progression. In lung cancer, Slug is the most thoroughly investigated EMT regulator. The expression of Slug is associated with lung cancer invasion and resistance to target therapy. In this review, we focus on the current understanding of the role of Slug in the carcinogenesis and progression of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665887     DOI: 10.1093/carcin/bgr110

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  136 in total

1.  Cordycepin induces human lung cancer cell apoptosis by inhibiting nitric oxide mediated ERK/Slug signaling pathway.

Authors:  Jung Hoo Hwang; Soo Jung Park; Won Gyu Ko; Seong-Mun Kang; Da Bin Lee; Junho Bang; Byung-Joo Park; Chung-Beum Wee; Dae Joon Kim; Ik-Soon Jang; Jae-Hong Ko
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Aileen Frayna; Ying Wang; Dawn S Chandler; Lynne V Abruzzo; Asif Rashid; Jaime Rodriguez; Guillermina Lozano; Yu Cao; Erica Lokken; Jinyun Chen; Marsha L Frazier; Aysegul A Sahin; Ignacio I Wistuba; Subrata Sen; Steven T Lott; Ann McNeill Killary
Journal:  Cancer Discov       Date:  2013-07-09       Impact factor: 39.397

3.  Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.

Authors:  Xiaopeng Liu; Hao Sun; Jing Qi; Linli Wang; Songwei He; Jing Liu; Chengqian Feng; Chunlan Chen; Wen Li; Yunqian Guo; Dajiang Qin; Guangjin Pan; Jiekai Chen; Duanqing Pei; Hui Zheng
Journal:  Nat Cell Biol       Date:  2013-05-26       Impact factor: 28.824

4.  A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Authors:  C-H Chen; P Thai; K Yoneda; K B Adler; P-C Yang; R Wu
Journal:  Oncogene       Date:  2013-08-19       Impact factor: 9.867

5.  The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.

Authors:  Juan Zhang; Dingjun Zhu; Qiongying Lv; Yuexiong Yi; Fei Li; Wei Zhang
Journal:  Tumour Biol       Date:  2015-07-10

6.  MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.

Authors:  Tonghui Cai; Xiaoying Guan; Hongyan Wang; Ying Fang; Jie Long; Xiaobin Xie; Yajie Zhang
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

7.  Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.

Authors:  Lei Ji; Jinjin Xu; Jian Liu; Ali Amjad; Kun Zhang; Qingwu Liu; Lei Zhou; Jianru Xiao; Xiaotao Li
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

8.  Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.

Authors:  Bruna Corominas-Faja; Cristina Oliveras-Ferraros; Elisabet Cuyàs; Antonio Segura-Carretero; Jorge Joven; Begoña Martin-Castillo; Enrique Barrajón-Catalán; Vicente Micol; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Cell Cycle       Date:  2013-09-17       Impact factor: 4.534

9.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression.

Authors:  Cheng-Hung Chou; Yi-Fang Cheng; Tiing Yee Siow; Amit Kumar; Konan Peck; Chen Chang
Journal:  Clin Exp Metastasis       Date:  2013-02-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.